250
Participants
Start Date
July 3, 2025
Primary Completion Date
January 31, 2028
Study Completion Date
January 31, 2029
[18F]FAPI-74 PET/CT
Patients included in the study will undergo FAPI-PET/CT after initial staging with gastroscopy and a contrast-enhanced CT of thorax and abdomen, but before undergoing a staging laparoscopy. Based on the results of the FAPI-PET/CT, the MDT and/or treating physician will decide on the next step: confirming possible malignant lesions on PET/CT by biopsies (either percutaneous of by staging laparoscopy), or in case of negative PET/CT, diagnostic laparoscopy.
[18F]-FAPI-74
\[18F\]-FAPI-74 will be administered intravenously 60 minutes before PET/CT-scanning to be able to detect (metastases of) gastric cancer
NOT_YET_RECRUITING
ZGT, Almelo
NOT_YET_RECRUITING
Amsterdam UMC, Amsterdam
NOT_YET_RECRUITING
Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam
NOT_YET_RECRUITING
Rijnstate, Arnhem
NOT_YET_RECRUITING
Catharina Ziekenhuis, Eindhoven
NOT_YET_RECRUITING
Zuyderland, Geleen
NOT_YET_RECRUITING
UMC Groningen, Groningen
RECRUITING
Leids Universitair Medisch Centrum, Leiden
NOT_YET_RECRUITING
Erasmus MC, Rotterdam
NOT_YET_RECRUITING
UMC Utrecht, Utrecht
Leiden University Medical Center
OTHER